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Translating the Mediterranean diet: from chemistry
to kitchen
Abstract
The Mediterranean diet has been an area of popular and scientific in-
trigue for more than 30 years. Research has focused on both whole-diet
compliance as well as individual component effects and many questions re-
main open as to the full spectrum of effects from this olive oil rich eating
pattern. This paper summarizes key findings related to the Mediterranean
diet including the health effects of olive oil as one tool in a whole-organism
approach to modifying risk factors for cardiovascular disease, cancer, meta-
bolic and other chronic illnesses. Suggestions for the utilization of these
findings are summarized in a new »Holistic Food Pyramid«, optimized ac-
cording to the basic principles of the Mediterranean diet and overall meta-
bolic needs.
INTRODUCTION
Biologically active compounds abound at both pharmacy and tablewith neither food nor drugs being expected to ever be able to com-
pletely substitute the other. Although modern pharmaceuticals are
commonly accepted as a miracle of the 20th century, we must remember
that food remains important to health as well. Dietary intake can en-
hance our possibilities to heal faster, reduce symptoms and minimize
disability.
The popularization of healthy diet design is no new phenomenon
and yet the average consumer can easily be left dazzled by the variety of
available approaches. Fortunately, medical professionals with a firm
understanding of the basic nutritional principles common to any diet
regimen can help guide their patients toward their best-suited options
based not only on personal preferences but also on the emerging under-
standings of expected health implications of specific dietary choices.
The Harvard School of Public Health, for example, has designed a
food pyramid that includes an active lifestyle plus a Mediterranean diet,
the same plan recommended by the World Health Organization (1).
This original paper is aimed at defining the components of the Med-
iterranean Diet, its adherence to basic nutritional dietary regimes and
its specific expected health effects.
CHEMISTRY: FOODS AND METABOLISM
All metabolic processes ideally adhere to one basic law: food and ox-
ygen provide for the production of carbon dioxide, water and energy.
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Essays
necessary for optimal chemical reactivity. The remainder
of the energy provided from food takes the form of en-
ergy-dense compounds such as ATP. Worth remember-
ing is that oxygen plays a vital role in allowing the opti-
mal processing of foodstuffs and that a deficiency of
oxygen, hypoxia, is a contributing step toward inflamma-
tion (2).
Essential dietary intake not only includes the macro-
nutrients composed of proteins, carbohydrates and lipids
but also micronutrient minerals and vitamins. Nutri-
tional supplements ensure a complete intake of micro-
nutrients (3) despite their dwindling quantities in foods
due to soil depletion and food processing (4). Water, the
milieu required for all bodily reactions, is one compo-
nent publicly understood to be part of necessary dietary
intake; however, given that it is also a metabolic product,
it contributes, in part, to the variability of the precise re-
quired daily water intake between individuals (5).
Although these fundamental components remain
the same for all humans, precisely how each individual
processes these nutrients is effected by the interplay of
many components, several on which we can exert direct
influence.
METABOLIC REGULATORS
The overall influence on metabolic regulation must
be considered with regard to intrinsic, internal, external
and epigenetic, contributors.
The intrinsic components include the hypothalamus,
the neuroendocrine control centre for most metabolic
processes. While hypothalamic function generally re-
mains within predictable ranges, the variable quantity
and composition of adipocytes between individuals is
most significant in its role as metabolically active tissue.
The ancient concept of fat serving only a benign insula-
tion and storage function must forever be abandoned in
recognition of its production of leptin, adiponectin and
resistin; proteins and peptides which collectively influ-
ence the balance of intake and expenditure coordinated
by the hypothalamus (6,7).
In addition to the hypothalamus and adipocytes, a
third intrinsic component, having been widely accepted
as such since the late 1990’s publication of »The Second
Brain«, is the intestinal tract (8). This massive system of
digestion and absorption is connected to metabolic regu-
lation as the location for 90% of the body’s serotonin re-
ceptors, a neurotransmitter well known to modulate mo-
od, satisfaction, pleasure and affect.
Furthermore, the digestive tract is now understood to
be highly influenced by another internal component of
metabolic regulation, the metabiome: the sum total of
cells, human and otherwise, within the body. No longer
simply a shocking concept, the reality of each 'human'
body containing only 10% self-cells with the remaining
90% being bacterial must be appreciated for its implica-
tions in overall bodily function (9). The vast array of gene
products provided by resident microbes is known to di-
versely supplement the host’s own metabolic processes
(10). This includes the extraction of energy from dietary
components, an association that is, for example, essential
with regard to polysaccharides and lipids (11).
The microbial-influenced capacity for energy extrac-
tion has been shown in animal models to be correlated to
body mass. The ability of enhanced energy extraction is
transmissible from obese to lean mice via the inoculation
of gut microbes from the former to the latter. That is,
germ-free lean mice can be converted to overly-exuber-
ant energy extraction and storage phenotypes by virtue of
providing them the gut flora of their obese counterparts
(12). Similarly, in humans, colonization with an obe-
sity-associated microbiota appears to precede the accu-
mulation of excess body fat (12). Further influences of
the microbiotia include modulation of neurohormones
and gut-derived lipids, short-chain fatty acids, triglyce-
ride clearance, vitamin biosynthesis, mucosa associated
immunity, inflammatory bowel disease and colorectal
cancer (10). Such associations make the discussion of
diet and health without considerations for the influence
of microbiota inherently incomplete. Dietary choices
from the start of life influence who we will carry with us
in our life’s journey: bacterial colonization of the gut be-
gins with food intake. We humans are communities of
cells living in perfect, functional harmony: not only do
we take care of our microbes but they take care of us.
External influences on metabolic regulation include
exposure to sunlight. Not only is this the signal for regu-
lation of circadian rhythms via the suprachiasmatic nu-
cleus of the hypothalamus (6), it has been hypothesized
as a potential confounder in the analysis of epidemiolo-
gic observations of health impacts from the Mediterra-
nean diet (13). Although worth considering, the repro-
ducibility of the health impact of the Mediterranean diet
in laboratory and cross-sectional studies worldwide sug-
gests this diet’s health impacts are independent of the
benefits of sunlight.
Therefore, two groups of non-human systems con-
sisting of internal (metabiome) and external influences
(sunlight, food) must be regarded in the spectrum of in-
fluences, with food being that with which we interact
most often. Considering the liable and various pheno-
types possible from such an array of contributors, no one
diet could reasonably be expected to suit all needs. All the
same, a growing body of evidence suggests that the Medi-




Epidemiologic evidence has shown a correlation be-
tween the dietary habits and health outcomes within the
Mediterranean region. In order to study this relation-
ship, however, the Mediterranean diet cannot simply be
assumed to be homogenous across geographies nor to re-
main static over time (14). During a 1993 international
conference, the Mediterranean diet was defined as one
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which abundantly contains plant-derived, minimally pro-
cessed foods which include olive oil as the main source of
fat, fresh fruits and nuts as the primary deserts, small
quantities of dairy products comprised mainly of cheese
and yogurt, low to moderate amounts of red wine with
meals, less than four eggs per week and red meat only oc-
casionally and in small quantities (15). These dietary
components traditionally associated with the Mediterra-
nean region were first brought to the attention of the
English-speaking world by American researcher Dr. An-
cel Keys (16). Although he’s often remembered for hav-
ing developed K-rations for combat soldiers in World
War II, he also conducted pioneering work on the effects
of starvation and introduced the concept of the body-
-mass index (BMI) assessment of body composition. Pre-
ceding and during his nearly 50 years of living in south-
ern Italy, Keys published studies and books on the health
benefits of Mediterranean diet and life-style (16).
Keys expounded on the important cardiovascular pro-
tective factors associated with Mediterranean diet. His
claims were based on decades of studying the epidemiol-
ogy of cardiovascular disease from which he made some
of the earliest claims that specific dietary fats correlate to
health risks (17). Studies such as the landmark 15-year
»Seven Countries Study« utilized habits, vital signs, bio-
chemical and hematological markers to follow the epide-
miology of disease in particular regions. With results
published between 1970 and 1986, Keys and his team
had strong evidence that death rates accelerated with in-
creased intake of saturated fatty acids, while monoun-
saturated fatty acids were associated with decreased car-
diovascular disease and increased longevity (17, 18).
Furthermore, in areas where olive oil served as the main
source of fat, all-cause cardiovascular disease and mor-
tality rates were low.
Finland, one of the participants in the »Seven Coun-
tries Study«, had, in 1970, massive health problems re-
lated to a lack of sunlight and an excess of butter, salt and
meats. Today, however, having conducted massive stud-
ies and implemented strategic interventions, this same
nation serves as an international role model for positive
health outcomes through progressive public health pro-
grams into the modifiable disease affecters associated
with diet (19).
The Mediterranean diet should therefore be consid-
ered to be inspired by, but not limited to, applications
within the Mediterranean region. Although there ap-
pears to be synergistic effects between the component in-
gredients (20), research into the Mediterranean diet has
largely centered on the association first noted by Keys:
the significance of olive oil as the main source of dietary
fat. The intervening 25 years since Keys’ first publication
have continued to demonstrate a strong correlation be-
tween improved cardiovascular profiles and the Mediter-
ranean diet as well as growing public acceptance of these
health benefits (21, 22).
CHEMISTRY: COMPONENTS AND THEIR
BIOLOGIC EFFECTS
Olive oil
Olive oil has been heavily researched with regard to
the activity of its individual components, as well as to
their potential synergistic effects when these constituents
remain combined in the form of the natural oil. Al-
though many studies have searched for the primary com-
ponent responsible for the health benefits associated with
olive oils, much evidence suggests that these are best ex-
plained by the combined effect of olive oil’s high mo-
nounsaturated fatty acid (MUFA) content along with
several classes of bioactive compounds (23, 24).
Oleic acid is the primary fatty acid of olive oil. Al-
though also present in other fats, this MUFA is found in
highest relative abundance in virgin olive oils (VOO)
(25). Oleic acid has been shown to improve several bio-
physical parameters including a three-fold positive im-
pact on biochemical contributors to cardiovascular disea-
se. Firstly, oleic acid augments production of high-den-
sity lipoprotein (HDL), the »good cholesterol« whose
level correlates with protection from cardiovascular dis-
ease. Inversely, harmful low-density lipoprotein (LDL),
the »bad cholesterol« most closely correlated to the devel-
opment of atherosclerosis, is meanwhile decreased by
oleic acid. Finally, although oxidized LDL enhances athe-
rosclerotic plaque development by promoting monocyte
chemotaxis, this process is additionally inhibited when
the LDL contains oleic acid (24).
Oleocanthal is the ester responsible for olive oil’s pun-
gent flavour. Inspired by the classic medicinal association
of bitterness in plants with potential pharmacologic pro-
perties, a research team in Barcelona demonstrated the
correlation between the intensity of bitterness in olive oil
with its anti-inflammatory effects (24). They confirmed
that the mechanism of action for oleocathal mimics ibu-
profen in that it inhibits the COX-1 and COX-2 en-
zymes (26). Additive as well as synergic effects on other
related physiological functions, such as LDL oxidation
and blood pressure, were also shown. Of note is ibu-
profen’s association with anti-platelet aggregation, de-
creased cancer and decreased Alzheimer’s-associated am-
yloid production (24), potent benefits which are neces-
sarily unexploited due to high-dose ibuprofen’s liver and
kidney toxicity (27).
Other authors doubt if the whole dose of olecanthal is
bioavailable in vivo and have described phenolics as the
source of olive oil’s anti-inflammatory properties (24). In
fact, refined olive oil (ROO) is devoid of many of these
biophenols and therefore only virgin olive oil is certain to
contain all the components that are likely contributing to
the anti-inflammatory properties of olive oil (24, 28).
Biophenols in olive oil increase the oxidative stability,
enhance the olive oil’s flavor and have been shown to be
highly bioavailable (23). This group includes hydroxy-
tyrosol, tyrosol and an oleuropein mixture, all of which
are biologically active agents (29). They have been sho-
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wn to contribute to the cardioprotective effects of olive
oil (29, 30).
Squalene, a component whose abundance in olive oil
is uniquely high compared to other fats, has been shown
to inhibit the activity of HMG-CoA reductase (31). This
key enzyme in the synthesis of cholesterol is the target for
the trusted statin class of cholesterol-lowering drugs, as
well as some new anti-inflammatory drugs. Additionally,
squalene has been shown to exert a protective effect
against colon carcinogenesis through its influences on
bile synthesis (32). Squalene was previously credited for
the decreased incidence of breast cancer observed in cer-
tain studies involving dietary olive oil (25). The mecha-
nism of impact on breast cancer requires more research
although it now appears to be more likely related to oleic
acid (33).
Tocopherols, including the alpha-tocopherol vitamin
E, are abundant in olives and olive oil. The ratio of vita-
min E and polyunsaturated fatty acids in olive oil is opti-
mal (34, 35). Vitamin E is associated with improving pa-
rameters related to nearly every process known to be
contributing factor in atherosclerosis. This spectrum of
activity includes increasing the resistance of LDL to oxi-
dation, decreasing the cytotoxic effects of oxidized LDL
on endothelial cells, inhibiting monocyte release of reac-
tive oxygen species and pro-inflammatory cytokines, in-
hibiting smooth muscle cell proliferation and increasing
the bioavailability of endothelial nitric oxide, to name a
few (36). The known anti-inflammatory properties of vi-
tamin E have been linked to observational studies docu-
menting reduced cardiovascular risk; however, a convinc-
ing etiologic connection remains to be confirmed (37).
Pigments are often regarded as a helpful visual guide
to the micronutrient content of fruits and vegetables. Ol-
ives and olive oil contain chlorophyll, a green pigment,
which has been suggested to have antioxidant and cancer
prevention effects. They also contain carotenoids that
were shown to act as provitamins and antioxidants, as
well as to have a role in the prevention and treatment of
cancer, cardiovascular, skin and eye disorders (38).
Aromatics, in particular trans-2-hexanal, are utilized
in the assessment of olive oil quality as they provide the
oil its aroma (22). While not generally considered to be
important pharmacologically, these compounds enhance
the olfactory and therefore gustatory experience of foods.
Red wine
Daily red wine consumption has been shown to have
a predictable correlation to mortality risk: one glass is
more protective than any other amount, including none
(39)! The recommended size of a 'glass' varies, with 0.3 –
– 0.4L being suggested for men while women should
only drink half as much. Furthermore, wine should be
taken with meals as alcohol consumed outside of meals
leads to the depletion of important coenzymes that can
contribute to disease (40).
The health benefits of red wine are, in part, attributed
to it being a natural and most concentrated source of
reservatrol. This polyphenol activates the sirtuin enzyme
SIRT-1 which is believed to promote survival in times of
stress (41, 42). This mechanism is credited for the car-
dioprotective and other health benefits of red wine but
there remains debate regarding the bioavailability of re-
servatrol and the precise therapeutic target in the body
(36, 41, 43).
Wine’s health benefits have been further shown to ex-
tend to the prevention of the formation of the neuro-
fibrillary plaques associated with Alzheimer’s disease
(44). This has contributed to the pursuit of sirtuins as
drug targets for neurodegenerative disorders like Parkin-
son’s and Alzheimer’s disease (42).
KITCHEN: LIFE-STYLE AND THE
UTILIZATION
Despite the plethora of claims that hold true about the
positive effects of components of the Mediterranean diet,
the most compelling evidence for their effectiveness co-
mes from the positive correlation between health out-
comes and the degree to which one adheres to the Medi-
terranean diet. That is to say, the simple addition of olive
oil to one’s meals is likely to decrease the risk for disease
development; however, the increased health benefits as-
sociated with a strictly Mediterranean diet are more than
additive. Using a variety of assessment techniques for
quantifying adherence to such a diet, the results have
consistently demonstrated reduced morbidity and mor-
tality with increased levels of adherence to the Mediterra-
nean diet (45). All the same, this cannot be considered to
be a fully elucidated diet plan as several key nutritional
guidelines are lacking, including recommendations about
calorie intake and the distribution of macronutrients. In
order to address these needs, we require a holistic per-
spective on the health benefits of the Mediterranean diet,
allowing it to provide a natural epidemiologic and scien-
tific foundation for individualizing diet schemes. Our
team has summarized these findings, along with nutri-
tional and life-style suggestions, in a new »Holistic Food
Pyramid« (Figure 1).
There is no single, generic food model nor can any
diet be designed without consideration for its role as part
of one’s life-style. Therefore, we shouldn’t speak only of
the Mediterranean diet in general but instead about ele-
ments of Mediterranean food and lifestyle. Dietary ad-
vice is incomplete if it lacks the recommendation to take
care of How and When to eat, not only what to eat.
The »How of eating« suggests a total life-style ap-
proach including adequate physical activity, sleep and
stress reduction. A life-style of eating well is impossible
without consideration for the availability of, and habits
involved in, healthy food selection. Although purchasing
costs may initially make some hesitant to add high qual-
ity olive oils and wines to their regular diet, the daily
quantities required for health benefits negate the up-
-front costs while promising huge gains in life-quality, in
part through added food diversity and flavors.
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Stress also plays a part in adherence to a healthy diet
in that excessive stress generally implies less time for
self-care. Excessive daily demands may result in less time
for, and focus on, food purchasing and preparation, the-
reby leading to increased reliance on convenience foods
(12). Stress resulting from a demanding daily schedule
may also require that meals are consumed as quickly as
possible, contrary to the classic advice for weight-man-
agement that slower eating allows satiety to register be-
fore too much food is consumed (46).
The »When of eating« must fit into a daily schedule
that includes adequate rest and exercise. The generally
accepted necessity of diet and exercise to be considered
concurrently is reflected in the modification of most
modern food pyramids to include exercise (1), a life-style
pattern which is essential for the future in that physical
activity, like adherence to a Mediterranean diet, is associ-
ated with decreased obesity in children (47).
Sleep has emerged as an additional life-style factor to
consider in healthy diet design wherein more sleep ap-
pears to help weight maintenance. Short sleepers, those
receiving less than seven hours nightly, have been shown
to have 15% higher serum levels of ghrelin, a peptide
which stimulates appetite, and 16% lower levels of leptin,
a hormone involved in increasing feelings of satiety (12).
The lack of leptin may lead to a state of over-nutrition,
which is associated with accumulation of triglycerides in
non-fat cells. Such fatty deposits cause lipotoxicity, which
is associated in the development of diseases such as type 2
diabetes, cardiomyopathy, and insulin resistance (10).
In summary, the spectrum of behavioural and nutri-
tional strategies that help to control appetite and energy
intake work cumulatively to tip the balance of the inter-
nal milieu from disease-prone toward healthy.
KITCHEN: UTILIZATION IN SPECIFIC
CONDITIONS
Inflammation
Inflammation is considered to be a key etiologic factor
for the development of illness and is common to meta-
bolic, neoplastic and cardiovascular diseases. The appro-
priate choice of nutritional components, such as those
found in the Mediterranean diet (Figure 1), provides a
non-pharmacologic means of preventing and decreasing
inflammation. These outcomes are generally measured
by improvements in markers such as c-reactive protein
(CRP), fibrinogen, homocysteine and LDL (45), chan-
ges that are considered substantial health benefits irre-
spective of weight or weight loss (48). All the same, a
healthy BMI provides health benefits that are in part ex-
plained by the inverse association between visceral fat
mass and anti-inflammatory adiponectin (49).
Obesity
Although too often regarded in the public eye as me-
rely an esthetic concern, obesity is a nutritional disorder
that can only be considered as an epidemic with devastat-
ing health implications. Currently, the number of people
worldwide who are obese is equal to the number who are
starving. In particular, most of the population of the
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Figure 1. The new »Holistic Food Pyramid«, optimized according to the basic principles of the Mediterranean diet, our metabolic needs and cellular
physiology.
United States will be obese by the late 2040’s, according
to the current trajectory (50).
Obesity is also an issue in Mediterranean countries, in
particular amongst children (47). This is attributable to
an increasingly sedentary lifestyle, as well as excess sug-
ary and salty snacks. In our era of rampant globalization,
geographic distribution is no longer a key determinant of
dietary choices and it is, in fact, the availability of West-
ern-style cheap foods and large chain stores that are tak-
ing their toll on dietary choices (51).
Obesity is now understood to be a chronic inflamma-
tory disease (9) that is largely influenced by the meta-
bolic activity of adipose tissue (52). In order to make best
use of the anti-inflammatory effects of the Mediterra-
nean diet, we must reduce the pro-inflammatory impact
of excess adipose tissue. Simple calorie reduction, like
red wine, activates SIRT-1 whose health benefits are ad-
ditive to those gained by this same measure leading to re-
duced adipocyte mass. Furthermore, increased inflam-
mation in the adipose tissue appears to be, in part, promo-
ted by elevated levels of bacterial-associated lipopolysa-
ccharide (LPS) in the gut (10, 53), thus furthering the
impetus to explore the microbiota for a means of inter-
vention in this metabolic disorder.
Glycemic Control
Monounsaturated fatty acids, such as those found in
olive oils, are associated with a protective effect on cell in-
sulin sensitivity and viability (54). This may largely be
the result of olive oil’s effect on thromboxane B (TXB).
This parameter is generally associated with and found el-
evated in diabetes and is lowered after only four days of
administering olive oil (24).
As blood glucose levels are adversely elevated by in-
flammation (52), the Mediterranean diet, with its abun-
dance of olive oil, provides a solid foundation on which
to personalize an anti-inflammatory diet, particularly for
those in need of glycemic control. The microbiome, a po-
tential target for modification, impacts insulin levels (10)
as does physical activity (54) thus reminding us that the
health benefits of a well-chosen diet are incomplete with-
out considering life-style choices as well.
Cancer
As a whole, adherence to the Mediterranean diet re-
duces the risk of some cancers (55) including breast can-
cer (56). Olive oil in particular has been associated epi-
demiologically with the reduction of or no increased risk
for the development of certain cancers, a factor that is
now attributable to olive squalene (23, 25).
Cardiovascular
The risk profile for cardiovascular disease (CVD) has
been shown to improve with utilization of a Mediterra-
nean-style diet (45). In the development of atherosclero-
sis, inflammation serves an integral role and as such,
interleukin-6 (IL-6), CRP and adiponectin are indica-
tors of coronary heart disease (CHD) activity (24, 57).
Stable CHD patients who supplement their diets with
virgin olive oil have been shown to have decreased levels
of pro-inflammatory IL-6 and CRP (24). Additionally,
anti-inflammatory adiponectin levels are increased with
adherence to Mediterranean diet (57).
The potential influence of the Mediterranean diet on
cardiovascular parameters being mediated through the
metagenome remains a largely unexplored area of re-
search. What has been demonstrated is that myocardial
substrate utilization is influenced by host-microbiome
interactions (10). Additionally, hypertension, another lea-
ding contributor to the development of cardiovascular
disease, is a parameter that may be impacted by the
metabiome (10). Although dietary intake of polyphenols
has been shown to impact the microbiome (58), bio-
phenol-rich olive oil and other components of the Medi-
terranean diet remain to be investigated with regard to
their metagenomic effects. There appears, however, to
remain a largely unexplored area into metagenomic tar-
gets of nutritional interventions for inflammation-medi-
ated diseases, a subject ripe with potential future preven-
tive health indications (59).
CONCLUSION
Although the search for deep understanding of the
nature of the connections between dietary constituents
and health outcomes can begin to appear to resemble a
quest for Shangri La, the indisputable epidemic of obe-
sity, a pro-inflammatory state, serves as one omnipresent
reminder of the need for deeper understanding of rea-
dily-available nutritional components which may help
tip the scales back toward a healthier future. In order to
move forward with a clear perspective of the utilization
of the Mediterranean diet, several questions remain to be
answered, such as, are there additional health benefits of
olive oil which have not yet been explored? To what ex-
tent are the anti-inflammatory biophenols of extra-virgin
olive oil absorbed? In what ways are these effects miti-
gated by the microbiome? How does the prevalence of
specific gut microbes change according to specific dietary
intake? Which dietary substances could provide the most
favorable metagenomic phenotypes?
With such a banquet feast of connections to be ex-
plored, we can consider the Mediterranean diet as a
well-made first course. Similar to the ancient Greek rec-
ipe for a long, happy life, Pan Metron Ariston (»all good
things in moderation«), food, rest and exercise, in bal-
ance, remain central to taking self-responsibility for min-
imizing the risks of disease development. Future investi-
gations can rely on the specific insights offered from
studies of the Mediterranean diet as one of many options
for orienting further study into the best advice for healthy
life-style shifts.
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